#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	34452	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2300	1478.5	0	.	n	.	0	C451T	SNP	451	451	C	832	832	T	1874	T,C,A	833,974,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	34452	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2300	1478.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1565	1565	C	1983	C	1914	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	64908	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3578	1792.6	0	.	n	.	0	T695C	SNP	695	695	T	1053	1053	C	2039	C,T	1943,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	64908	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3578	1792.6	0	.	n	.	0	A1638G	SNP	1638	1638	A	1996	1996	G	2041	G,A	1430,532	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	64908	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3578	1792.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2329	2329	C	1957	C,T	1873,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	64908	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3578	1792.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2403	2403	A	1958	A	1885	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	64908	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3578	1792.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2955	2955	C	1928	C,A	1853,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	64908	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3578	1792.6	0	HET	.	.	.	T2085C	.	2085	2085	T	2443	2443	T	1956	T,C	1377,504	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	64908	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3578	1792.6	0	HET	.	.	.	G256C	.	256	256	G	614	614	G	2067	G,C	1342,487	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	3950	folP	855	855	100.0	folP.l15.c4.ctg.1	1521	256.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1073	1075	AGC	405;408;406	A;G;C,T	388;391;386,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	13092	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3279	393.7	1	SNP	p	S91F	1	.	.	271	273	TTC	499	501	TTC	451;448;446	T,C;T;C	426,1;427;420	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	13092	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3279	393.7	1	SNP	p	D95G	1	.	.	283	285	GGC	511	513	GGC	434;435;436	G,C,A;G,A;C	414,1,1;417,1;413	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	13092	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3279	393.7	1	SNP	p	G95N	0	.	.	283	285	GGC	511	513	GGC	434;435;436	G,C,A;G,A;C	414,1,1;417,1;413	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	3632	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1164	306.7	1	SNP	p	G45D	0	.	.	133	135	GGC	423	425	GGC	436;428;427	G;G;C	418;414;410	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1848	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	831	215.8	0	.	n	.	0	A197.	DEL	197	197	A	471	471	A	428	A	414	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	11888	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3005	389.7	1	SNP	p	D86N	0	.	.	256	258	GAC	517	519	GAC	477;479;481	G;A,G;C	460;448,1;465	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	11888	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3005	389.7	1	SNP	p	S87R	1	.	.	259	261	CGT	520	522	CGT	487;486;488	C;G;T	471;469;467	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	11888	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3005	389.7	1	SNP	p	R87W	0	.	.	259	261	CGT	520	522	CGT	487;486;488	C;G;T	471;469;467	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	11888	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3005	389.7	1	SNP	p	R87I	0	.	.	259	261	CGT	520	522	CGT	487;486;488	C;G;T	471;469;467	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	11888	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3005	389.7	1	SNP	p	S88P	0	.	.	262	264	TCC	523	525	TCC	493;492;488	T;C;C	474;474;468	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	8840	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2599	336.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1477	1479	GGC	453;448;445	G;G;C	427;425;417	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	9062	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2401	371.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1302	1304	GCC	477;476;479	G;C,T;C	461;458,1;461	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	9062	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2401	371.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1305	1307	ATG	481;485;490	A;T;G	464;471;472	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	9062	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2401	371.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1317	1319	ACC	491;492;498	A;C;C	461;471;472	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	9062	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2401	371.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1317	1319	ACC	491;492;498	A;C;C	461;471;472	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	9062	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2401	371.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1818	1820	ACC	450;449;453	A,C;C;C	423,1;428;435	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	9062	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2401	371.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1872	1874	GCG	443;446;444	G;C,T;G	435;435,1;433	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	9062	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2401	371.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1872	1874	GCG	443;446;444	G;C,T;G	435;435,1;433	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	9062	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2401	371.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1995	1997	GGT	347;348;345	G,A;G;T,C	330,1;330;321,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	9062	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2401	371.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2004	2006	AGC	318;316;316	A,G;G;C	303,1;304;304	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	9062	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2401	371.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2022	2024	CCG	241;242;244	C,G;C,G;G,GGC	207,11;214,3;204,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	13458	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3186	417.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1673	1675	CCG	485;486;481	C;C;G	450;461;447	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	5536	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1826	298.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	609	609	C	379	C	361	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	6538	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1494	429.8	0	.	p	.	0	Q143K	NONSYN	427	429	CAA	650	652	AAA	551;552;550	A,C;A;A	527,6;535;531	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	6538	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1494	429.8	0	.	p	.	0	G210R	NONSYN	628	630	GGA	851	853	AGA	542;533;527	A,G;G;A,G	521,4;515;510,2	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	6538	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1494	429.8	0	.	p	.	0	S217G	NONSYN	649	651	AGT	872	874	GGT	514;519;520	G,A;G;T	493,1;502;490	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	6538	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1494	429.8	1	SNP	p	G120K	1	.	.	358	360	AAG	581	583	AAG	494;496;498	A;A,G;G,T	469;483,1;467,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	6538	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1494	429.8	1	SNP	p	N121D	0	.	.	361	363	AAC	584	586	AAC	499;500;501	A;A,C;C,A	483;486,2;474,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	6538	porB1b	1038	1038	99.71	porB1b.l15.c4.ctg.1	1494	429.8	1	SNP	p	A121N	1	.	.	361	363	AAC	584	586	AAC	499;500;501	A;A,C;C,A	483;486,2;474,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	23264	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4808	476.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	2712	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	930	285.9	1	SNP	p	V57M	1	.	.	169	171	ATG	444	446	ATG	531;531;534	A;T;G	516;513;517	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
